In a note to clients on Wednesday, BTIG downgraded Unity shares to Sell from Neutral, arguing that the stock’s recent rally, up more than 40% month-to-date, “overstates the fundamental benefit from an ...

Detailed price information for Northrop Grumman Corp (NOC-N) from The Globe and Mail including charting and trades.

Detailed price information for Domino's Pizza Inc (DPZ-Q) from The Globe and Mail including charting and trades.

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that the ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the ...

BTIG’s assessment suggested the company leveraged favorable industry trends and gained market share as it heads into earnings ...

To schedule a one-on-one meeting with management, please reach out to your BTIG representative.

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

BTIG analyst Andre Madrid raised the firm’s price target on Northrop Grumman (NOC) to $630 from $575 and keeps a Buy rating on the shares.